| 12/23/2020 |
Here are the top 5 Houston startup venture capital deals in 2020 |
|
... Vivo Capital along with support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific, and the Samsung Catalyst Fund.The funds were raised in order "to accelerate investment in salesforce expansion, technology and product innovation and further development of clinical evidence supporting its flagship solution," according to the news release."We are pleased to have Vivo Capital and Novo Holdings as new investors, and with this funding we ... |
| 12/23/2020 |
Texas expert: Coworking in Houston isn’t going away — it's evolving |
|
... Vivo Capital along with support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific, and the Samsung Catalyst Fund.The funds were raised in order "to accelerate investment in salesforce expansion, technology and product innovation and further development of clinical evidence supporting its flagship solution," according to the news release."We are pleased to have Vivo Capital and Novo Holdings as new investors, and with this funding we ... |
| 12/22/2020 |
Ambyint's $15M series B - InnovationMap |
|
... Vivo Capital along with support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific, and the Samsung Catalyst Fund.The funds were raised in order "to accelerate investment in salesforce expansion, technology and product innovation and further development of clinical evidence supporting its flagship solution," according to the news release."We are pleased to have Vivo Capital and Novo Holdings as new investors, and with this funding we ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |
| 7/15/2020 |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital |
PR Newswire |
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence News provided by Jul 15, 2020, 09:30 ET Share ... S, as well as significant support from existing investors, including Merck Global Health Innovation Fund, Boston Scientific and Samsung Catalyst Fund. "Vivo is extremely pleased to partner with Jon Otterstatter and his management team, Merck ... |